Barbiturates assay

For the quantitative in vitro determination of Barbiturates in urine. This product is suitable for automated, semi-automated and manual use.

SKU: DA4008 Categories: , , , , , , , , , Method: Homogeneous Enzyme Immunoassay Format: Liquid Size: R1 2x16.9ml, R2 2x8ml Assay Range: n/a Working Stability: To expiry at +2 to +8°C Available Applications: Applications are available for a wide range of instruments Tags: , , , , ,

$889.02

In stock

Quantity

$889.02

In stock

Description

Intended Use

For the quantitative in vitro determination of Barbiturates in urine. This product is suitable for automated, semi-automated and manual use.

Clinical Significance

Barbiturates are central nervous system depressants. They are used therapeutically as sedatives, hypnotics, and anticonvulsants. Barbiturates are almost always taken orally as capsules or tablets. The effects resemble those of intoxication with alcohol. Chronic use of Barbiturates leads to tolerance and physical dependence. Short acting Barbiturates taken at 400 mg/day for 2 to 3 months produces a clinically significant degree of physical dependence.

 

Withdrawal symptoms experienced during periods of drug abstinence can be severe enough to cause death. Only a small amount (less than 5%) of most Barbiturates are excreted unaltered in the urine. The detection period for the Barbiturates in the urine is 4 to 7 days.

Product Availability

Product Availability

Product availability may vary from country to country